doi: 10.3389/fcimb.2025.1488264 Received 29 August 2024 Accepted 24 February 2025 Published 11 March 2025 Volume 15 - 2025 Edited by Xiangtian Yu, Shanghai Jiao Tong University, China Reviewed by Zeneng Wang, Cleveland Clinic, United States Lin Chen, Northwest University, China Updates Copyright 2025 Su, Wu, Wang, Xie, Xiao, Su, Tang and Yao
According to the same poll, 40% of users say they took them primarily for weight loss, while 60% were using GLP-1s to treat a chronic condition including diabetes or heart disease
Key Ingredients L-Carnitine & CLA Each 10 ml contains 20 g of L-Carnitine combined with CLA, formulated to enhance fat metabolism and promote overall health
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis